Nancy Dvorin

Managing Editor

20 Years of Experience


@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Articles from Nancy Dvorin:

Regulatory & Reimbursement

FDA Output October 2019

Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, and Warning Letters in October 2019.

Read Article